Latest Share Chat

DIRECTOR DEALINGS: Fund Linked To Proteome Non-Exec Buys Shares

Tue, 31st Jul 2018 17:45

LONDON (Alliance News) - Proteome Sciences PLC said on Tuesday Vulpes Life Sciences Fund bought shares in the company on Friday.

Proteome Non-Executive Martin Diggle is also a director of Vulpes Investment Management.

Vulpes Life Sciences bought 525,000 shares at 3.49 pence each and 118,000 shares at 3.50p each. In total, the fund bought 643,000 shares at an average price of 3.492p.

Following this transaction, Vulpes - and Diggle - hold an 18.98% interest in Proteome, or in 56.0 million shares.

Shares in Proteome closed down 6.4% at 3.50p on Tuesday.

Related Shares

More News

16 May 2024 12:23

IN BRIEF: Proteome Sciences promises AGM return to growth in 2024

Proteome Sciences PLC - London-based protein-focused drug development services provider - Proteome tells annual general meeting on Thursday it is "con...

16 May 2024 10:41

AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

26 Apr 2024 11:18

Proteome wins GBP500,000 deal to supply mass spectrometry services

(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrome...

26 Apr 2024 10:40

AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

26 Apr 2024 09:45

Proteome Sciences secures contract win with US biopharmaceutical firm

(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's ma...